No recent analyst price targets found for CSCIF.
Latest News for CSCIF

COSCIENS Provides Strategic Update
TORONTO, ONTARIO, March 05, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”) today announced that the Company has made a strategic decision to cease funding its German subsidiaries, Aeterna Zentaris GmbH and Zentaris IVF GmbH (the “German Subsidiaries”). As a result, the Company expects the German Subsidiaries to commence a structured insolvency process in the…
GlobeNewsWire • Mar 5, 2026
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CSCIF.
Senate Trading
No Senate trades found for CSCIF.
U.S. House Trading
No House trades found for CSCIF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
